BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singla N, Xie Z, Zhang Z, Gao M, Yousuf Q, Onabolu O, McKenzie T, Tcheuyap VT, Ma Y, Choi J, McKay R, Christie A, Torras OR, Bowman IA, Margulis V, Pedrosa I, Przybycin C, Wang T, Kapur P, Rini B, Brugarolas J. Pancreatic tropism of metastatic renal cell carcinoma. JCI Insight 2020;5:134564. [PMID: 32271170 DOI: 10.1172/jci.insight.134564] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Rossi E, Bersanelli M, Gelibter AJ, Borsellino N, Caserta C, Doni L, Maruzzo M, Mosca A, Pisano C, Verzoni E, Zucali PA. Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient? Curr Oncol Rep 2021;23:147. [PMID: 34748099 DOI: 10.1007/s11912-021-01140-9] [Reference Citation Analysis]
2 Pirasteh A, Lovrec P, Pedrosa I. Imaging and its Impact on Defining the Oligometastatic State. Semin Radiat Oncol 2021;31:186-99. [PMID: 34090645 DOI: 10.1016/j.semradonc.2021.03.006] [Reference Citation Analysis]
3 Elias R, Tcheuyap VT, Kaushik AK, Singla N, Gao M, Reig Torras O, Christie A, Mulgaonkar A, Woolford L, Stevens C, Kettimuthu KP, Pavia-Jimenez A, Boroughs LK, Joyce A, Dakanali M, Notgrass H, Margulis V, Cadeddu JA, Pedrosa I, Williams NS, Sun X, DeBerardinis RJ, Öz OK, Zhong H, Seshagiri S, Modrusan Z, Cantarel BL, Kapur P, Brugarolas J. A renal cell carcinoma tumorgraft platform to advance precision medicine. Cell Rep 2021;37:110055. [PMID: 34818533 DOI: 10.1016/j.celrep.2021.110055] [Reference Citation Analysis]
4 Malleo G, Salvia R, Maggino L, Marchegiani G, D'Angelica M, DeMatteo R, Kingham P, Pulvirenti A, Sereni E, Jarnagin WR, Bassi C, Allen PJ, Butturini G. Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma. Ann Surg Oncol 2021;28:3100-8. [PMID: 33575870 DOI: 10.1245/s10434-021-09649-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sellner F, Thalhammer S, Klimpfinger M. Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma. Cancers (Basel) 2021;13:1342. [PMID: 33809634 DOI: 10.3390/cancers13061342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 All S, Garant A, Hannan R. Stereotactic Ablative Radiation (SAbR) for Oligometastatic RCC. Semin Radiat Oncol 2021;31:227-34. [PMID: 34090649 DOI: 10.1016/j.semradonc.2021.02.002] [Reference Citation Analysis]
7 Shaya JA, Lin X, Weise N, Cabal A, Panian J, Derweesh IH, McKay RR. Prognostic Significance of Pancreatic Metastases in Patients With Advanced Renal Cell Carcinoma Treated With Systemic Therapy. Clin Genitourin Cancer 2021:S1558-7673(21)00091-4. [PMID: 34176762 DOI: 10.1016/j.clgc.2021.04.006] [Reference Citation Analysis]
8 Okamoto T. Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer. World J Gastroenterol 2022; 28(10): 985-1008 [DOI: 10.3748/wjg.v28.i10.985] [Reference Citation Analysis]
9 Silagy AW, Kotecha RR, Weng S, Holmes A, Singla N, Mano R, Attalla K, Weiss KL, DiNatale RG, Patil S, Coleman JA, Motzer RJ, Russo P, Voss MH, Hakimi AA. Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma. Cancer 2021. [PMID: 34286865 DOI: 10.1002/cncr.33790] [Reference Citation Analysis]
10 Laruelle A, Manini C, Iñarra E, López JI. Metastasis, an Example of Evolvability. Cancers (Basel) 2021;13:3653. [PMID: 34359555 DOI: 10.3390/cancers13153653] [Reference Citation Analysis]
11 Tjahjono R, Phung D, Gurney H, Gupta R, Riffat F, Palme CE. Thyroid gland metastasis from renal cell carcinoma: a case series and literature review. ANZ J Surg 2021;91:708-15. [PMID: 33319504 DOI: 10.1111/ans.16482] [Reference Citation Analysis]
12 Haeberle L, Busch M, Kirchner J, Fluegen G, Antoch G, Knoefel WT, Esposito I. Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report. J Med Case Rep 2021;15:314. [PMID: 34059139 DOI: 10.1186/s13256-021-02768-8] [Reference Citation Analysis]
13 Chanez B, Caillol F, Ratone JP, Pesenti C, Rochigneux P, Pignot G, Thomassin J, Brunelle S, Walz J, Salem N, Giovannini M, Gravis G. Endoscopic Ultrasound-Guided Radiofrequency Ablation as an Future Alternative to Pancreatectomy for Pancreatic Metastases from Renal Cell Carcinoma: A Prospective Study. Cancers (Basel) 2021;13:5267. [PMID: 34771431 DOI: 10.3390/cancers13215267] [Reference Citation Analysis]
14 Mollica V, Rizzo A, Tassinari E, Giunchi F, Schiavina R, Fiorentino M, Brunocilla E, Ardizzoni A, Massari F. Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study. Anticancer Drugs 2021;32:74-81. [PMID: 33290315 DOI: 10.1097/CAD.0000000000001017] [Reference Citation Analysis]
15 Böning G, Adelt S, Feldhaus F, Fehrenbach U, Kahn J, Hamm B, Streitparth F. Spectral CT in clinical routine imaging of neuroendocrine neoplasms. Clin Radiol 2021;76:348-57. [PMID: 33610290 DOI: 10.1016/j.crad.2020.12.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tucker MD, Rini BI. Predicting Response to Immunotherapy in Metastatic Renal Cell Carcinoma. Cancers (Basel) 2020;12:E2662. [PMID: 32961934 DOI: 10.3390/cancers12092662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Roussel E, Kinget L, Verbiest A, Boeckx B, Zucman-Rossi J, Couchy G, Caruso S, Baldewijns M, Joniau S, Van Poppel H, Lambrechts D, Albersen M, Beuselinck B. Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications. Acta Oncol 2021;60:1499-506. [PMID: 34448678 DOI: 10.1080/0284186X.2021.1962971] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
18 Sauter-meyerhoff C, Bohnert R, Mazzola P, Stühler V, Kandabarau S, Büttner FA, Winter S, Herrmann L, Rausch S, Hennenlotter J, Fend F, Scharpf M, Stenzl A, Ossowski S, Bedke J, Schwab M, Schaeffeler E. Characterization of Genetic Heterogeneity in Recurrent Metastases of Renal Cell Carcinoma. Cancers 2021;13:6221. [DOI: 10.3390/cancers13246221] [Reference Citation Analysis]
19 Rasmussen RG, Xi Y, Sibley RC 3rd, Lee C, Cadeddu JA, Pedrosa I. Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance. AJR Am J Roentgenol 2021. [PMID: 34286596 DOI: 10.2214/AJR.21.25979] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lin E, Liu X, Liu Y, Zhang Z, Xie L, Tian K, Liu J, Yu Y. Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma. Front Immunol 2021;12:653358. [PMID: 33746989 DOI: 10.3389/fimmu.2021.653358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Itamoto S, Abe T, Oshita A, Hanada K, Nakahara M, Noriyuki T. Repeat pancreatic resection for metachronous pancreatic metastasis from renal cell carcinoma: A case report. Int J Surg Case Rep 2022;94:107022. [PMID: 35398785 DOI: 10.1016/j.ijscr.2022.107022] [Reference Citation Analysis]
22 Santoni M, Massari F, Aurilio G, Mollica V, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Nolé F, Montironi R. Designing novel immunocombinations in metastatic renal cell carcinoma. Immunotherapy 2020;12:1257-68. [PMID: 32998603 DOI: 10.2217/imt-2020-0144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Dudani S, de Velasco G, Wells JC, Gan CL, Donskov F, Porta C, Fraccon A, Pasini F, Lee JL, Hansen A, Bjarnason GA, Beuselinck B, Pal SK, Yuasa T, Kroeger N, Kanesvaran R, Reaume MN, Canil C, Choueiri TK, Heng DYC. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival. JAMA Netw Open 2021;4:e2021869. [PMID: 33475752 DOI: 10.1001/jamanetworkopen.2020.21869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
24 Sellner F, Thalhammer S, Klimpfinger M. Isolated Pancreatic Metastases of Renal Cell Cancer: Genetics and Epigenetics of an Unusual Tumour Entity. Cancers 2022;14:1539. [DOI: 10.3390/cancers14061539] [Reference Citation Analysis]
25 Singla N. Rational Therapeutic Sequencing in Metastatic Renal Cell Carcinoma: Insights Gained from IMmotion150. Eur Urol 2021;79:674-5. [PMID: 33608152 DOI: 10.1016/j.eururo.2021.01.043] [Reference Citation Analysis]
26 Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Timmerman R, Brugarolas J, Hannan R. Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Adv Radiat Oncol 2021;6:100692. [PMID: 34646963 DOI: 10.1016/j.adro.2021.100692] [Reference Citation Analysis]
27 Shiuan E, Reddy A, Dudzinski SO, Lim AR, Sugiura A, Hongo R, Young K, Liu XD, Smith CC, O'Neal J, Dahlman KB, McAlister R, Chen B, Ruma K, Roscoe N, Bender J, Ward J, Kim JY, Vaupel C, Bordeaux J, Ganesan S, Mayer TM, Riedlinger GM, Vincent BG, Davis NB, Haake SM, Rathmell JC, Jonasch E, Rini BI, Rathmell WK, Beckermann KE. Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma. Cancers (Basel) 2021;13:1475. [PMID: 33806963 DOI: 10.3390/cancers13061475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Principe DR, Schulte BC, Kamath SD, Munshi HG. Glandular metastases from renal cell carcinoma show poor clinical responses to immune checkpoint inhibition but durable responses to angiogenesis inhibitors. BMJ Case Rep 2021;14:e243259. [PMID: 34158333 DOI: 10.1136/bcr-2021-243259] [Reference Citation Analysis]